Tom Gwydir Power - 18 Aug 2021 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Director
Signature
/s/ Christopher Melsha as attorney-in-fact for Tom Gwydir pursuant to power of attorney previously filed.
Issuer symbol
NEPH
Transactions as of
18 Aug 2021
Net transactions value
+$38,200
Form type
4
Filing time
19 Aug 2021, 21:04:35 UTC
Next filing
16 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEPH Common Stock Purchase $38,200 +5,000 +83% $7.64* 11,031 18 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEPH Stock Option (right to buy) 9,627 18 Aug 2021 Common Stock 9,627 $5.31 Direct F1
holding NEPH Stock Option (right to buy) 5,568 18 Aug 2021 Common Stock 5,568 $8.57 Direct F2
holding NEPH Stock Option (right to buy) 6,850 18 Aug 2021 Common Stock 6,850 $8.06 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 This option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21.
F3 This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23.